Evaluates anti-inflammatory effects of Carex kobomugi extract in macrophage cells, suggesting its potential as a therapeutic agent.
This study aimed to evaluate the anti-inflammatory effects of Carex kobomugi extract on skin, using the RAW 264.7 macrophage cell line. The anti-inflammatory effects of C. kobomugi extract were evaluated by examining cell viability, gene expressions, and the levels of nitric oxide (NO)/prostaglandin E₂ (PGE₂) in RAW 264.7 cells. Pro-inflammatory gene expression (IL-1α, IL-1β, IL-6, TNF-α) and the levels of NO/PGE₂ were analyzed to elucidate the anti-inflammatory effects of C. kobomugi extract. Quantitative real-time polymerase chain reaction (Real-time RT-qPCR) analysis revealed a significant decrease in the mRNA levels of IL-1α/β, IL-6 and TNF-α following treatment with C. kobomugi extract. Furthermore, reduced levels of PGE₂ and NO confirmed that C. kobomugi extract possesses anti-inflammatory properties. These results suggest that C. kobomugi extract contains bioactive compounds capable of modulating inflammatory responses. Further studies on the mechanisms underlying its anti-inflammatory effects could contribute to the development of cosmeceutical products as well as pharmacological therapies.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: